Abstract
Signal transduction pathways play a central role in the regulation of cellular behavior, including growth and differentiation. It has been known for some time that the toxicity of many cancer chemotherapeutic agents is dependent on the activity of the biochemical pathway which they target. The hypothesis which we have been investigating is that growth factors, hormones and chemicals that activate signal transduction pathways can influence sensitivity to cisplatin (DDP). These studies have been conducted using ovarian carcinoma cell lines because they are representative of a type of tumor that is usually initially responsive to DDP chemotherapy in vivo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrews, P.A., Howell, S.B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2:35–43, 1990.
Andrews, P.A., Jones, J.A., Varki, N.M., Howell, S.B. Rapid emergence of acquired cis-diamminedichloroplatinum (II) resistance in an in vivo model of human ovarian carcinoma. Cancer Comm., 2:93–100, 1990.
Simmonds, A.P., and McDonald, E.C. Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay. Br. J. Cancer, 50:317–326, 1984.
Inoue, K., Mukaiyama, T., and Ogawa, M. In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor cologenic assay. Cancer Chemother. Pharmacol., 15:208–213, 1985.
Wilson, A.P., Ford, C.H.J., Newman, C.E., and Howell, A. Cisplatinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumor cells from patients receiving high dose cisplatinum as first line treatment. Br. J. Cancer, 56:763–773, 1987.
Wolf, C.R., Hayward, I.P., Lawrie, S.S., Buckton, K., Mclntyre, M.A., Adams, D.J., Lewis, A.D., Scott, A.A.R., and Smyth, J.F. Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int. J. Cancer, 39:695–702, 1987.
DiSaia, P.J., Sinkovics, J.G., Rutlege, F.N., Smith, J.P. Cell-mediated immunity to human malignant cells. Am. J. Obstet. Gynecol., 114:979–989, 1972.
Isonishi, S., Andrews, P.A., and Howell, S.B. Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem., 265:3623–3627, 1990.
Seamon, K.B., Padgett, W., and Daly, J.W. Forskolin: a unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci., USA, 78:3363–3367, 1981.
Chou, T.C., and Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22:27–55, 1984.
Roskoski, R. Assays of protein kinase. Meth. Enzymol., 99:3–6, 1983.
Ferguson, P.J., and Cheng, Y.C. Transient protection of cultured human cells against antitumor agents by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res., 47:433–441, 1987.
Erusalimsky, J.D., Friedberg, I., and Rozengurt, E. Bombesin, diacylglycerols, and phorbol esters rapidly stimulate the phosphorylation of an Mr = 80,000 protein kinase C substrate in permiabilized 3T3 cells. J. Biol. Chem., 263:19188–19194, 1988.
Brenner, D.A., O’Hara, M., Angel, P., Chojkier, M., and Karin, M. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α. Nature, 337:661–663, 1989.
Bell, R.M. Protein kinase C activation by diacylglycerol second messengers. Cell, 45:631–632, 1986.
Christen, R.D., Hom, D.K., Porter, D.C., Andrews, P.A., MacLeod, C.L, and Howell, S.B. Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin. J. Clin. Invest., 86:1632–1640, 1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Howell, S.B., Isonishi, S., Christen, R.C., Andrews, P.A., Mann, S.C., Hom, D. (1991). Signal Transduction Pathway Regulation of DDP Sensitivity. In: Howell, S.B. (eds) Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0738-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0738-7_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0740-0
Online ISBN: 978-1-4899-0738-7
eBook Packages: Springer Book Archive